Prosecution Insights
Last updated: April 19, 2026

Hk Inno N Corporation

6 pending office actions

Portfolio Summary

6
Total Pending OAs
2
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18283478 ADENOSINE DERIVATIVE HAVING ANTAGONISTIC ACTION ON A2A AND A3 ADENOSINE RECEPTORS AND METHOD FOR PREPARING SAME CHO, DAVID H 1693 Non-Final OA Sep 22, 2023
18282177 CRYSTALLINE FORM OF HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR DAHLIN, HEATHER RAQUEL 1629 Non-Final OA Sep 14, 2023
18269421 PHARMACEUTICAL COMPOSITION COMPRISING TEGOPRAZAN AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS NGUYEN, JOHN P 1619 Non-Final OA Jun 23, 2023
17802054 PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND GOTFREDSON, GAREN 1619 Final Rejection Aug 24, 2022
17802078 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION KWON, JOHN SEUNGJAI 1615 Final Rejection Aug 24, 2022
17429732 PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND HUTTER, GILLIAN A 1625 Non-Final OA Aug 10, 2021

Managing Hk Inno N Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month